Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS)

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

NCT02248142 ·Status: COMPLETED

Non-interventional Observational Study of Pramipexole in Restless Legs Syndrome: Impact on Quality of Life

NCT00539461 ·Status: COMPLETED

A Study in Patients Suffering From Idiopathic Restless Legs Syndrome Who Responded to a Preceding, 6-month Treatment With Open-label Pramipexole Including Titration (0.125, 0.25, 0.5, 0.75 mg Orally q.n.)

NCT00152958 ·Status: COMPLETED ·Phase: PHASE3

Observational Study of Sifrol® in Patients With Primary Restless Legs Syndrome (RLS)

NCT02248155 ·Status: COMPLETED

Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS)

NCT00133198 ·Status: COMPLETED ·Phase: PHASE3

Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome

NCT00721279 ·Status: COMPLETED

A 6 Week Trial to Study the Efficacy and Safety of a Starting Dose 0.25 mg Pramipexole (Mirapex) in Patients With RLS

NCT00375284 ·Status: COMPLETED ·Phase: PHASE4

Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients

NCT00806026 ·Status: COMPLETED ·Phase: PHASE3

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

NCT00314860 ·Status: COMPLETED ·Phase: PHASE3

Non-interventional Observational Study on the Influence of Pramipexole on Sensory Symptoms of Restless Legs Syndrome (RLS)

NCT00887289 ·Status: COMPLETED

Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

NCT05214963 ·Status: COMPLETED ·Phase: NA

Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)

NCT01521663 ·Status: COMPLETED ·Phase: PHASE2

Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)

NCT00256854 ·Status: COMPLETED ·Phase: PHASE3

SWITCH:Restless Legs Patients Switched to Ropinirole From Pramipexole

NCT00344994 ·Status: COMPLETED ·Phase: PHASE4

Pramipexole for Restless Leg Syndrome in Peritoneal Dialysis Patients

NCT03817554 ·Status: TERMINATED ·Phase: PHASE4

Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS

NCT01170091 ·Status: COMPLETED

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

NCT00530790 ·Status: COMPLETED ·Phase: PHASE2

Ropinirole XR (Extended Release) In Patients With Restless Legs Syndrome

NCT00197080 ·Status: COMPLETED ·Phase: PHASE3

Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)

NCT01084551 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Research Study Evaluating Ropinirole Treatment For Restless Legs Syndrome (RLS)

NCT00225862 ·Status: COMPLETED ·Phase: PHASE3

Autonomic Function and Cardiovascular Risk in Restless Legs Syndrome

NCT02025608 ·Status: COMPLETED ·Phase: PHASE4

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

NCT02231918 ·Status: COMPLETED ·Phase: PHASE2

A Placebo-Controlled Study for SPM 962 in Restless Legs Syndrome (RLS) Patients

NCT00666965 ·Status: COMPLETED ·Phase: PHASE2

Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)

NCT00996944 ·Status: TERMINATED ·Phase: PHASE2

Multiple Dose Bioequivalence Study of Pramipexole Extended Release in Chinese Healthy Male Volunteers

NCT01214109 ·Status: COMPLETED ·Phase: PHASE1